Is JNJ a good investment in 2026?

Johnson & Johnson trades at a P/E ratio of 21.6, with medium volatility (17.0% annualized). The stock is in a consolidation phase.

What is the risk level of JNJ?

Based on 30-day volatility of 17.0%, JNJ has MEDIUM risk. Beta of 0.33 indicates lower sensitivity to market movements than average.

Johnson & Johnson (JNJ) Stock Analysis & Price Target

Q: Does JNJ pay dividends?

Yes, Johnson & Johnson has a dividend yield of 2.14%.

Key Metrics

MARKET CAP

$574.40B

P/E RATIO

21.6

BETA

0.33

Less volatile

DIV YIELD

2.14%

52W HIGH

$251.71

52W LOW

$141.50

VOLATILITY

17.0%

30d annualized

Price Performance

30-DAY PRICE CHART

$243.33 → $238.35-2.05%

30 days agoToday

1-YEAR PERFORMANCE

$163.63 → $238.35+45.7%

JNJ | 52-week chartLast updated: 3/17/2026

Healthcare Sector Context

Defensive sector including pharmaceuticals, biotech, medical devices, and healthcare services.

METRIC	JNJ	SECTOR AVG	VS SECTOR
P/E Ratio	21.6x	22.0x	↓ 2%
Beta	0.33	0.85	Less volatile
Div Yield	2.14%	1.50%	Above avg
30d Volatility	17.0%	22%	Lower risk

TOP HEALTHCARE PEERS

UNH PFPFE ABABBV

Competitors Analysis

Compare JNJ's key metrics against its main healthcare sector competitors.

COMPANY	PRICE	MARKET CAP	SECTOR
JNJ(You are here)	$238.35	$574.40B	Healthcare	—
UNH	$287.06	$260.56B	Healthcare	VIEW →
PFPFE	$27.70	$157.54B	Healthcare	VIEW →
ABABBV	$221.79	$392.16B	Healthcare	VIEW →

Click on a competitor to view their full analysis

Technical Analysis

Johnson & Johnson is currently trading at $238.35, which is 5.3% below its 52-week high. With a beta of 0.33, the stock shows lower sensitivity to market movements.

RSI (14)NEUTRAL

30-DAY TRENDNEUTRAL

VOLUME3.1M(Below avg)

Frequently Asked Questions

Is JNJ a good buy right now?

Johnson & Johnson trades at 21.6x earnings. This is near market average. Current risk level is Medium based on 17.0% volatility.

Does JNJ pay dividends?

Yes, Johnson & Johnson offers a dividend yield of 2.14%. This translates to approximately $5.10 per share annually.

How volatile is JNJ?

With 30-day annualized volatility of 17.0% and beta of 0.33,JNJ is classified as Medium risk. The stock tends to be more stable than the market average.

Related Assets

LLLLYANALYZE →

Eli Lilly and Company

Track JNJ Live

Add Johnson & Johnson to your Portfolio Terminal for real-time alerts and risk updates.

OPEN TERMINAL IMPORT BROKER FILE

Last updated: 3/17/2026, 7:21:50 PM